Engineering of phosphatidylcholine-based solid lipid nanocarriers for flavonoids delivery

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 460, Issue , 2014, Pages 483-493

  Bazylińska, Urszula ^a   Pucek, Agata ^a   Sowa, Michał ^a   Matczak Jon, Ewa ^a   Wilk, Kazimiera A ^a  

^a WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Baicalein; Cocrystal; Hot homogenization ultrasonification; Microemulsification; Myricetin; Solid lipid nanoparticles; Solvent diffusion; Stability; Structural studies

Indexed keywords

BIOCOMPATIBILITY; CONTROLLED DRUG DELIVERY; CONVERGENCE OF NUMERICAL METHODS; DIFFUSION; EMULSIFICATION; FABRICATION; NANOPARTICLES; POLYPHENOLIC COMPOUNDS; SOLVENTS; SYNTHESIS (CHEMICAL); TARGETED DRUG DELIVERY; X RAY POWDER DIFFRACTION;

BAICALEIN; CO-CRYSTALS; MICROEMULSIFICATION; MYRICETIN; SOLID LIPID NANOPARTICLE (SLN); SOLVENT DIFFUSION; STRUCTURAL STUDIES; ULTRASONIFICATION;

FLAVONOIDS;

BAICALEIN; CAFFEINE; FLAVONOID; LIPID; MYRICETIN; NANOCARRIER; NICOTINAMIDE; PHOSPHATIDYLCHOLINE; PIRACETAM; POLYPHENOL DERIVATIVE; POLYSORBATE 80; SOLID LIPID NANOPARTICLE;

ANALYTIC METHOD; ARTICLE; BIOCOMPATIBILITY; CRYSTAL STRUCTURE; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG STABILITY; HOMOGENIZATION ULTRASONIFICATION METHOD; INFRARED SPECTROSCOPY; MICROEMULSIFICATION; NANOENGINEERING; PARTICLE SIZE; PROCEDURES; SOLVENT DIFFUSION METHOD; X RAY POWDER DIFFRACTION;

EID: 84907103454     PISSN: 09277757     EISSN: 18734359     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2014.02.034     Document Type: Article

References (41)

1. Mu¨ller R.H., Radtke M., Wissing S.A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 2002, 54(Suppl. 1):S131-S155.
2. Ekambaram P., Sathali A.H., Priyanka H. Solid lipid nanoparticles: a review. Sci. Rev. Chem. Commun. 2012, 2:80-102.
3. Garud A., Singh D., Garud N. Solid lipid nanoparticles (SLN): method, characterization and applications. Int. Curr. Pharm. J. 2012, 1:384-393.
4. S. Weber, A. Zimmer, J. Pardeike, Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application: a review of the state of the art, Eur. J. Pharm. Biopharm. (2013). doi:10.1016/j.ejpb.2013.08.013.
5. Martins S.M., Sarmento B., Nunes C., Lu´cio M., Reis S., Ferreira D.C. Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration. Eur. J. Pharm. Biopharm. 2013, 85:488-502.
6. Mu¨ller R.H., Mehnert W., Lucks J.S., Schwarz C., zur Mu¨hlen A., Weyhers H., Freitas C., Ru¨hl D. Solid lipid nanoparticles (SLN)-analternative colloidal carrier system for controlled drug delivery. Eur. J. Pharm. Biopharm. 1995, 41:62-69.
7. Schubert M.A., Muller-Goymann C.C. Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier. Eur. J. Pharm. Biopharm. 2005, 61:77-86.
8. Mehnert W., Ma¨der K. Solid lipid nanoparticles. Production, characterization and applications. Adv. Drug Deliv. Rev. 2012, 64:83-101.
9. Gardouh A.R., Gad S., Ghonaim H.M., Ghorab M.M. Design and characterization of glyceryl monostearate solid lipid nanoparticles prepared by high shear homogenization. Brit. J. Pharm. Res. 2013, 3:326-346.
10. Mojahedian M.M., Daneshamouz S., Samani S.M., Zargaran A. A novel method to produce solid lipid nanoparticles using n-butanol as an additional co-surfactant according to the o/w microemulsion quenching technique. Chem. Phys. Lipids 2013, 174:32-38.
11. Sailaja A.K., Amareshwar P., Chakravarty P. Formulation of solid lipid nanoparticles and their applications. Curr. Pharm. Res. 2011, 1:197-203.
12. Joshi A.S., Patel H.S., Belgamwar V.S., Agrawal A., Tekade A.R. Solid lipid nanoparticles of ondansetron HCl for intranasal delivery: development, optimization and evaluation. J. Mater. Sci.: Mater. Med. 2012, 23:2163-2175.
13. Franc¸ois S., Hatem F. Industrial technologies and scale up. Microencapsulation: Methods and Industrial Implications 2006, 149-182. Taylor and Francis, New York. 2nd ed. S. Benita (Ed.).
14. McClements D.J. Advances in fabrication of emulsions with enhanced functionality using structural design principles. Curr. Opin. Colloid Interface Sci. 2012, 17:235-245.
15. Attama A.A., Muller-Goymann C.C. Effect of beeswax modification on the lipid matrix and solid lipid nanoparticle crystallinity. Colloid Surf. A: Physicochem. Eng. Aspects 2008, 315:189-195.
16. Bunjes H., Koch M.H.J., Westesen K. Influence of emulsifiers on the crystallization of solid lipid nanoparticles. J. Pharm. Sci. 2003, 92:1509-1520.
17. Chandni S., Viral S., Umesh U. Solid lipid nanoparticles: a review. Curr. Pharm. Res. 2011, 1:351-368.
18. Sharma P.K., Reilly M.J., Jones D.N., Robinson P.M., Bhatia S.R. The effect of pharmaceuticals on the nanoscale structure of PEO-PPO-PEO micelles. Colloids Surf. B: Biointerfaces 2008, 61:53-60.
19. U. Bazylin´ska, A. Lewin´ska, Ł. Lamch, K. A. Wilk, Polymeric nanocapsules and nanospheres for encapsulation and long sustained release of hydrophobic cyanine-type photosensitizer, Colloid Surf. A: Physicochem. Eng. Aspects (2013). doi:10.1016/j.colsurfa.2013.02.023.
20. Bazylin´ska U., Pietkiewicz J., Saczko J., Nattich-Rak M., Rossowska J., Garbiec A., Wilk K.A. Nanoemulsion-templated multilayer nanocapsules for cyanine-type photosensitizer delivery to human breast carcinoma cells. Eur. J. Pharm. Sci. 2012, 47:406-420.
21. Bazylin´ska U., Skrzela R., Szczepanowicz K., Warszyn´ski P., Wilk K.A. Novel approach to long sustained multilayer nanocapsules: influence of surfactant head groups and polyelectrolyte layer number on the release of hydrophobic compounds. Soft Matter 2011, 7:6113-6124.
22. Skrzela R., Para G., Warszyn´ski P., Wilk K.A. Experimental and theoretical approach to nonequivalent adsorption of novel dicephalic ammonium surfactants at the air/solution interface. J. Phys. Chem. B. 2010, 114:10471-10480.
23. Yucel U., Elias R.J., Coupland J.N. Localization and reactivity of a hydrophobic solute in lecithin and caseinate stabilized solid lipid nanoparticles and nanoemulsions. J. Colloid Interface Sci. 2013, 394:20-25.
24. Smith A.J., Kavuru P., Wojtas L., Zaworotko M.J., Shytle R.D. Cocrystals of quercetin with improved solubility and oral bioavailability. Mol. Pharm. 2011, 8:1867-1876.
25. Sowa M., S´lepokura K., Matczak-Jon E. Cocrystals of fisetin, luteolin and genistein with pyridinecarboxamide coformers: crystal structures, analysis of intermolecular interactions, spectral and thermal characterization. CrystEngComm. 2013, 15:7696-7708.
26. Sowa M., S´lepokura K., Matczak-Jon E. A 1:1 cocrystal of baicalein with nicotinamide. Acta Crystallogr. C. 2012, 68:o262-0265.
27. Qiao N., Li M., Schlindwein W., Malek N., Davies A., Trappitt G. Pharmaceutical cocrystals: an overview. Int. J. Pharm. 2011, 419:1-11.
28. Shan N., Zaworotko M.J. The role of cocrystals in pharmaceutical science. Drug Discov. Today 2011, 419:1-11.
29. Sowa M., S´lepokura K., Matczak-Jon E. A 1:1 pharmaceutical cocrystal of myricetin in combination with uncommon piracetam conformer: X-ray single crystal analysis and mechanochemical synthesis. J. Mol. Struct. 2014, 1058:114-121.
30. M. Sowa, E. Matczak-Jon, K. S´lepokura, Myricetin-caffeine cocrystal and methods of myricetin-caffeine cocrystal syntheses, Patent application P401410.
31. Irache J.M., Esparza I., Gamazo C., Agu¨eros M., Espuelas S. Nanomedicine novel approaches in human and veterinary therapeutics. Vet. Parasitol. 2011, 180:47-71.
32. Wilk K.A., Zielin´ska K., Hamerska-Dudra A., Jezierski Adam Biocompatible microemulsions of dicephalic aldonamide-type surfactants: formulation, structure and temperature influence. J. Colloid Interface Sci. 2009, 334:87-95.
33. Domagalska B.W., Wilk K.A., Wysocki S. Effect of the solvent environment on the spectroscopic properties of the donor-acceptor conjugated polyenes. Experimental and theoretical investigations. Phys. Chem. Chem. Phys. 2003, 5:696-701.
34. Pietkiewicz J., Zielin´ska K., Saczko J., Kulbacka J., Majkowski M., Wilk K.A. New approach to hydrophobic cyanine-type photosensitizer delivery using polymeric oil-cored nanocarriers: hemolytic activity, in vitro cytotoxicity and localization in cancer cells. Eur. J. Pharm. Sci. 2010, 39:322-335.
35. Costa Silva L.F., Kasten G., Maduro de Campos C.E., Chinelatto A.L., Lemos-Senna E. Preparation and characterization of quercetin-loaded solid lipid microparticles for pulmonary delivery. Powder Technol. 2013, 239:183-192.
36. Masson D.S., Morais G.G., de Morais J.M., de Andrade F.F., Dos Santos O.D.H., de Oliveira W.P., Rocha Filho P.A. Polyhydroxy alcohols and peach oil addition influence on liquid crystal formation and rheological behavior of o/w emulsions. J. Dispersion Sci. Technol. 2005, 26:463-468.
37. Kumar S., Randhawa J.K. Preparation and characterization of Paliperidone loaded solid lipid nanoparticles. Colloids Surf. B. Biointerfaces 2013, 102:562-568.
38. Livney Y.D., Assaraf Y.G. Rationally designed nanovehicles to overcome cancer chemoresistance. Adv. Drug Deliv. Rev. 2013, 65:1716-1730.
39. Jung M.S., Kim J.S., Kim M.S., Alhalaweh A., Cho W., Hwang S.J., Velaga S.P. Bioavailability of indomethacin-saccharin cocrystals. J. Pharm. Pharmacol. 2010, 62:1560-1568.
40. McNamara D.P., Childs S.L., Giordano J., Iarriccio A., Cassidy J., Shet M.S., Mannion R., O'Donnell E., Park A. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. Pharm. Res. 2006, 23:1888-1897.
41. Fathi M., Varshosaz J., Mohebbi M., Shahidi F. Hesperetin-loaded solid lipid nanoparticles and nanostructure lipid carriers for food fortification: preparation, characterization, and modeling. Food Bioprocess. Technol. 2013, 6:1464-1475.